Clinical Trial Update: Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis

View source ↗

Summary

This is a retrospective analysis using 18F-DOPA PET/CT to assess heterogeneity in metastatic neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Snippet

Sponsor: University Medical Center Groningen | Conditions: Neuroendocrine Tumors | Status: COMPLETED